Phoenix, which tracks the birth control shopping patterns of 1,000 women each month, predicts a battle among brands to become first choice preference will heat up the DTC market by the end of the year.
Durham, NC (PRWEB) November 13, 2012
OBGYN’s expect one-third (32%) of their patients to immediately demand to be switched to a free option as soon their 2013 health plans take effect, according to a Phoenix Healthcare national poll. These doctors also believe that few of their patients (19%) will know which brands they can choose from for free. Phoenix, which tracks the birth control shopping patterns of 1,000 women each month, predicts a battle among brands to become first choice preference will heat up the DTC market by the end of the year.
The poll was conducted over the weekend of October 27-28 by Phoenix Healthcare in partnership with MedePolls. Phoenix Healthcare’s 360° Marketview studies measure patient brand usage and advertising awareness among nearly pharmaceutical’s highest spending categories including: Contraceptives, Dyslipidemia, Schizophrenia, Rheumatoid Arthritis, Plaque Psoriasis, Crohn’s Disease, Psoriatic Arthritis, Ankylosing Spondylitis, and Men’s Health. A partial list of the major brands tracked in these programs include: Abilify, Actemra, AndroGel, Cialis, Cimzia, Ella, Enbrel, Essure, Generess FE, Humira, Invega Sustenna, Januvia, Levitra, Lo Loestrin FE, Mirena, Niaspan, Orencia, Ortho Evra and Ortho TriCyclen-Lo, ParaGard, Plan B, Rapiflo, Remicade, Rituxan, Seroquel XR, Simponi, Stelara, Uloric, Viagra, Victoza, and Zyprexa Relprevv.
For poll results and more information about the kind of brand tracking information is available in the 360° Contraceptive Marketview© study contact John Duggan at 508-315-6184 or john.duggan(at)phoenixmi(dot)com. For more information about MedePolls, please contact our Brendan Egan at 212-328-8003, brendan.egan(at)medefield(dot)com.